An avoidable adverse drug reaction: Nicolau syndrome.
Department of Dermatology, Ankara Polatli Duatepe State Hospital, Ankara, Turkey.
Duygu
D
Gulseren
Department of Dermatology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Emine Buket
EB
Sahin
Department of Pathology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Onder
O
Bozdogan
Faculty of Medicine, Department of Dermatology, Hitit University, Çorum, Turkey.
Ferda
F
Artuz
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D004008:Diclofenac / Q000009:adverse effects* / Q000627:therapeutic use*; D065127:Dopamine D2 Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular / Q000009:adverse effects* / Q000379:methods; D008787:Metoclopramide / Q000009:adverse effects* / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D065148:Nicolau Syndrome / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D065127:Dopamine D2 Receptor Antagonists; D004008:Diclofenac; D008787:Metoclopramide